Heart Failure
1st Edition
Published on 27. December 2004
Book
Hardback
600 pages
978-0-8247-5827-1 (ISBN)
Description
This impressive guide authoritatively summarizes the fundamental cellular and molecular abnormalities associated with heart failure, as well as current invasive and noninvasive diagnostic techniques, the latest pharmacological advances, device-based therapies, surgical options, and evolving molecular treatments-surpassing any other text on the topic with concise discussions of recent molecular discoveries in pathophysiology alongside practical clinical approaches to the diagnosis and treatment of heart failure patients.
More details
Series
Language
English
Place of publication
New York
United States
Publishing group
Taylor & Francis Inc
Target group
Professional and scholarly
Clinical and interventional cardiologists, transplant cardiologists and coordinators, pulmonologists, immunologists, and residents and fellows in these disciplines.
Illustrations
24 s/w Photographien bzw. Rasterbilder
24 Halftones, black and white
Dimensions
Height: 254 mm
Width: 178 mm
Weight
1225 gr
ISBN-13
978-0-8247-5827-1 (9780824758271)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Content
Cellular and Molecular Basis for Heart Failure. Genetics of Dilated and Hypertrophic Cardiomyopathies. Hypertrophy and Hypertrophic Signaling in Heart Failure. Myocardial Cell Death: Apoptosis versus Necrosis in Heart Failure. Excitation-Contraction Coupling in Heart Failure. Beta-Receptor Signaling in Heart Failure. Pathophysiology of Heart Failure. Ventricular Remodeling and Secondary Valvular Dysfunction in Heart Failure Progression. Neurohormonal and Cytokine Activation. Cardiomyopathies in the Adult (Dilated, Hypertrophic and Restrictive Diseases). Heart Failure with Normal Systolic Function. Clinical Heart Failure: Diagnosis and Treatment. The Clinical Syndrome of Heart Failure. Predicting Prognosis in Heart Failure. Conventional Therapy (digoxin, diuretics, ACE inhibitors). Beta-adrenergic Blockers. Angiotensin Receptor Antagonists. Aldosterone Antagonists. New Pharmacologic Therapies (TNF, Endothelin antagonists, BNP). Treatment of Diastolic Heart Failure. Cardiac Resynchronization Therapy. Management of Atrial and Ventricular Arrhythmias in Heart Failure. Heart Failure in Special Populations (women, elderly, minorities, renal insufficiency, pulmonary disease, thyroid disease). Practice Guideline for Heart Failure Management. Surgical Options for Heart Failure. Coronary Revascularization/Mitral Valve Repair/Remodeling Procedures (Achorn device, Myosplint, Dor). Cardiac Transplantation and Long-term Mechanical Circulatory Support. Targeted Gene Transfer in Heart Failure. Cellular Transplantation.